Sunshine Biopharma SBFM
NASDAQ SBFM
$2.75 +0.04 (+1.48%)
At close: Nov 9, 2026 · 4:00 PM EST

Sunshine Biopharma (SBFM) Liabilities from Discontinued Operations (2018 - 2019)

Updated

Sunshine Biopharma (SBFM) posted Liabilities from Discontinued Operations of $103,732 for Q2 2019, unchanged from the prior quarter.

Analysis

Sunshine Biopharma (SBFM) Liabilities from Discontinued Operations (2018 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Sunshine Biopharma 187,731.50 -38.90 Mn 2.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 103,732.00
Mar 31, 2019 103,732.00
Dec 31, 2018 103,732.00
API Access

Sunshine Biopharma Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=SBFM&period=max&api_key=YOUR_API_KEY